Literature DB >> 14251902

RATE OF METABOLISM OF TOLBUTAMIDE IN TEST SUBJECTS WITH LIVER DISEASE OR WITH IMPAIRED RENAL FUNCTION.

E NELSON.   

Abstract

Entities:  

Keywords:  BLOOD; CHEMISTRY; KIDNEY DISEASES; LIVER CIRRHOSIS; LIVER DISEASES; METABOLISM; PHARMACOLOGY; TOLBUTAMIDE

Mesh:

Substances:

Year:  1964        PMID: 14251902     DOI: 10.1097/00000441-196412000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  13 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Histological changes in the liver and indices of drug metabolism in alcoholics.

Authors:  E A Sotaniemi; J Ahlqvist; R O Pelkonen; H Pirttiaho; P V Luoma
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

Review 3.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

4.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

5.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Drug metabolism in liver disease.

Authors:  L F Prescott; J A Forrest; K K Adjepon-Yamoah; N D Finlayson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

Review 7.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

9.  Determinants of serum antipyrine half-lives in patients with liver disease.

Authors:  R A Branch; C M Herbert; A E Read
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

10.  Altered elimination of antipyrine in patients with acute viral hepatitis.

Authors:  D A Burnett; A J Barak; D J Tuma; M F Sorrell
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.